FDA Investigator William F Lagud, Jr

William F Lagud, Jr has conducted inspections on 443 sites in 12 countries as of 11 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
443
Last Inspection Date:
11 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100007550
Countries of Inspections:
Germany, United States of America, Italy, United Kingdom of Great Britain and Northern Ireland, Georgia, Australia, Spain, Portugal, Czechia, Belgium, Ukraine, Brazil
FDA Investigators that have inspected at least one site in common with William F Lagud, Jr:
Abby Lmozeke Baker, Adam J Taylor, Albert F Peacock, PhD, Alysia C Alger, Amanda J White, Ana Djurdjevic, Ana P Barido, Andrew A Hoopes, Andrew K Schaal, Angel F Colon, Anita R Michael, Annette Melendez, Anthony E Keller, RPh, Anya Dlockett Evans, April K Hill, Ashlee M Ward, Barbara D Wright, Barbara G Peoples, Bobbi J Miller, Bonita S Chester, Bonnie E Pierson, Bonnie L Menzel, Brenda C Hamilton, Brent T Hall, Brent W Higgs, Brentley S Collins, Brett R Havranek, Brian D Nicholson, Brian R Cronenwett, Brian Sanders, Camilla S Smith, Candace S Tucker, Carl J Montgomery, Carmen Y Fisher, Catherine Whiteside, PhD, Christina A Miller, Christina L Bigham, Clara E Santiago, Cody D Rickman, Connie L Hannon Rabel, Creighton T Tuzon, Cynthia Jim, CSO, Dana D Carter, SR DDS, Danial S Hutchison, Daniel Pst Laurent, Daniel R Hurt, Daniel Sagardia Vazquez, Darla J Christopher, Darrah, David L Miser, Dawn C Olenjack, Deborah Kleinfeld, Deborah S Hammond, Debra Lboyd Seale, Decarlos A Gomez, Denise L Burosh, Dennis R Hudson, Diana K Krepel, Diana M Guidry, Diane Hall, Dianiris C Ayala, Dina K West, Dolores Harper, Donna D Gallien, MPH, Dwight D Ferguson, Edward E Lockwood (EEL), Elizabeth L Holmes, Elmina E Akwo, Elmina E Mboh, Emily B Camire, Emily S Mcgann, Eric C Fox, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric T Huebler, Erma Zaimova, Esther A Ofori, Everard A Irish, Fabian Nchaparro Rodriguez, Farhana Khan, Gail L Katz, Garrad R Poole, George Ivan Wey, Gerald Mierle, German Rivera, Ginger M Sykes, Heath W Cartwright, Henry E Sanchez, Hoimay Chan, Howard A Burmester, Ingrid Y Johnson, James D Planchon, James J Houlihan, James L Finn, James R Montero, Jane E Nelson, Janet B Abt, Janete A Eaker, Janete A Oliveira, Janice M Hickok, Jeanne J Chiu, Jeanne J Thai, Jeffery A Hangartner, Jeffery L Sumter, Jeffrey B Moody, Jennifer T Szymanski, Jessica E Hensley, Jessica L Peterson, Jessie E Morris, Jin Young Park, PhD, Joan A Loreng, Jodi M Gatica, John A Iwen, John Cook, John J Welsh, PhD, Johnson, Jose Martinez, Jr, Joseph G Kramer, Joseph L Despins, PhD, Joseph R Lambert, Joyce B Watson, Judy Ellen Ciaraldi, Julie N Vosilus, Ka L Wong, Kaarin M Slotte, Kara L Roden, Karen M Montgomery (KMM), Karlton T Watson, Kathleen B Swat, Kathleen J Close, Kelly D Moore, Kelly D Sheppard, Kenneth S Boehnen, Kevin A Beavers, Kimberly A Dux, Kip J Hanks, Kristi M Hampton Thurston, La Tasham Gunter, Laura E Garcia, Lauren E Skokan, Lauren M Lilly, PhD, Laurie A Haxel, Laurissa S Flowers, Laverne Puckett, LCDR Audra J Lenhart, LCDR Ismael Olvera, IV, LCDR Matthew J Morrison, LCDR Matthew R Mcnew, MPH, REHS/RS, Lee Terry Moore, Leena Thomas, Lewis K Antwi, Linda K Cline, Linda R Kuchenthal, Linhart, Lisa L Caulder, Lisa L Flores, Lisa R Jennings, Lori A Gioia, Louis S Chen, Lourdes R Genera, Luis A Carrion, Lynn L Wong, Lynnette I Riggio, Maira P Brading, Marc A Jackson, Jr, Margaret Torres Vazquez, Marijo B Kambere, PhD, Marion D Wimberly, Jr, Marion W Nadeau, Mark I Kaspar, Marlene L Davis, Mary E Baker Brown, Mary Ewilkerson Brinsko, Mary L Schuckmann, Mary T Carden, Maryann Ruff, Mathur, Matthew A Walburger, Matthew J Gretkierewicz, Matthew J Sienko, Matthew R Sleeter, Melinda L Rice, Melissa D Kalik, Melissa J Holz, Melva J Palmer, Merelynn Rhoten, Michael A Feingold, Michael D Robinson, Michael E Maselli, Michael S Kopf, Michele D Thompson, Michele M Falchek, Michelle C Webb, Michelle Paxon, Minerva Rogers, Monica J Wilkins, Monica M Mcclure, Monique M Brooks, Monique S Frazier, Nadine Nanko Johnson, Nancy G Schmidt, Nancy T Waites, Nankon, Naseem S Jouhari, Nathan R Moon, Nerming V Briones, Nicole J Conklin, Nimmy Mathews, Pamela L Velez Vega, Patricia M Jacobs, Patty P Kaewussdangkul, Pauline N Logan, Ramon Lgonzalez Prieto, Randy V Bong, Rebecca T Davis, Richard L Bartlett, Richard L Rutherford, Robert D Tollefsen, Robert J Nesselhauf, Robert M Tillman, Robert R Wilson, Roberta W Cunningham, Ronda Rloyd Jones, Samuel K Gibbons, Jr, Sarah A Palmer, Sarah E Morris, Scott A Jepson, Scott T Ballard, Sergio E Delgado, Shanna R Haden, Sherri J Jackson, Sherry G Bous, Siv K Si, Sondra L Phillips, Stephanie Mangigian, MS/OSH, RN, Stephen T Hansen, Steven P Allen, Stroman, Stuart W Russell, Susan M Miller, Tamara J Umscheid, Tania Y Hall, Tara C Alcazar, Ted L Anderson, Teena H Aiken, Telicia R White, Terrance L Thomas, Thuy T Nguyen, LCDR, Toby Vern H Hill, Tonia L Sawyer, Traci C Kelm, Tracy J Washington, Tristian E Strait, Uruaku A Obasi, Vickie J Kanion, Victoria A Wagoner, Walsworth, Warren J Lopicka, Weston K Szymanski, William C Corley, William J Foust, Yaw O Osei, Young M Yoon, Yvonne C Wilkes, Zoey A Trombley

William F Lagud, Jr's Documents

Publish Date Document Type Title
August, 2008 FDA 483 Midwest Women's Healthcare Specialists - Form 483, 2008-08-19
July, 2002 EIR Midwest Transplant Network - EIR, 2002-07-31
January, 2014 EIR CSL Plasma, Inc. - EIR, 2014-01-31
January, 2014 FDA 483 CSL Plasma, Inc. - Form 483, 2014-01-31
July, 2008 FDA 483 Midwest Reproductive Center PA - Form 483, 2008-07-17
March, 2023 FDA 483 American National Red Cross (The), Lewis and Clark Region - Form 483, 2023-03-31
July, 2019 EIR BioLife Plasma Services L.P. - EIR, 2019-07-15
December, 2021 FDA 483 Vitti Labs, LLC - Form 483, 2021-12-20
February, 2012 FDA 483 CSL Plasma Inc. - Form 483, 2012-02-03
September, 2000 FDA 483 Innovative Blood Resources d.b.a. Nebraska Community Blood Bank - Form 483, 2000-09-01
August, 2002 FDA 483 CHI Health Good Samaritan - Form 483, 2002-08-30
December, 2000 FDA 483 Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc. - Form 483, 2000-12-01
January, 2023 FDA 483 Utah Cord Bank LLC - Form 483, 2023-01-06
February, 2012 FDA 483 Response CSL Plasma Inc. - Form 483R, 2012-02-13
March, 2002 EIR Labette County Medical Center - EIR, 2002-03-06
January, 2023 FDA 483 FIOR Bioscience LLC - Form 483, 2023-01-06
February, 2000 FDA 483 Aventis Bio-Services - Form 483, 2000-02-24
February, 2012 EIR CSL Plasma Inc. - EIR, 2012-02-03
March, 2023 FDA 483 KUPI Reproductive Endocrinology & Infertility Lab - Form 483, 2023-03-06
June, 2019 FDA 483 Response Oklahoma Blood Institute - Sylvan N Goldman Center - Form 483R, 2019-06-24
August, 2002 EIR CHI Health Good Samaritan - EIR, 2002-08-30
September, 2023 FDA 483 Re-Gen Active Lab Inc - Form 483, 2023-09-21
December, 2000 EIR Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc. - EIR, 2000-12-01
June, 2002 EIR Community Blood Cntr of Grtr KC - EIR, 2002-06-10
March, 2024 FDA 483 Fertility Specialists of Texas PLLC. - Form 483, 2024-03-29
May, 2012 FDA 483 Primus Corporation dba Trinity Biotech - Form 483, 2012-05-18
February, 2019 FDA 483 Midwest Transplant Network - Form 483, 2019-02-19
August, 2021 FDA 483 St Luke's Hospital Assisted Reproductive Technology Lab - Form 483, 2021-09-22
September, 2000 FDA 483 Response Innovative Blood Resources d.b.a. Nebraska Community Blood Bank - Form 483R, 2000-09-18
September, 2000 EIR Innovative Blood Resources d.b.a. Nebraska Community Blood Bank - EIR, 2000-09-01
June, 2010 FDA 483 Cerner Corporation, Corporate Headquarters - Form 483, 2010-06-01
July, 2017 FDA 483 California Stem Cell Treatment - Form 483, 2017-07-26
July, 2002 FDA 483 Midwest Transplant Network - Form 483, 2002-07-31
June, 2013 FDA 483 Lorch Ulrike - Form 483, 2013-06-21
November, 2019 FDA 483 Ascension Via Christi Hospitals Wichita Inc - Form 483, 2019-11-18
June, 2019 FDA 483 Oklahoma Blood Institute - Sylvan N Goldman Center - Form 483, 2019-06-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more